Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Total Liabilities: 2013-2020

Historic Total Liabilities for Larimar Therapeutics (LRMR) over the last 7 years, with Sep 2020 value amounting to $11.3 million.

  • Larimar Therapeutics' Total Liabilities fell 65.72% to $11.3 million in Q3 2020 from the same period last year, while for Sep 2020 it was $11.3 million, marking a year-over-year decrease of 65.72%. This contributed to the annual value of $5.9 million for FY2019, which is 79.31% down from last year.
  • Larimar Therapeutics' Total Liabilities amounted to $11.3 million in Q3 2020, which was down 12.37% from $12.9 million recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Total Liabilities ranged from a high of $33.0 million in Q3 2019 and a low of $5.9 million during Q4 2019.
  • Moreover, its 3-year median value for Total Liabilities was $27.8 million (2018), whereas its average is $23.4 million.
  • Per our database at Business Quant, Larimar Therapeutics' Total Liabilities spiked by 298.18% in 2018 and then plummeted by 79.31% in 2019.
  • Quarterly analysis of 5 years shows Larimar Therapeutics' Total Liabilities stood at $9.9 million in 2016, then skyrocketed by 175.85% to $27.3 million in 2017, then grew by 4.39% to $28.5 million in 2018, then tumbled by 79.31% to $5.9 million in 2019, then crashed by 65.72% to $11.3 million in 2020.
  • Its Total Liabilities was $11.3 million in Q3 2020, compared to $12.9 million in Q2 2020 and $23.0 million in Q1 2020.